Genomics Biotechnology & Emerging Medical Technologies Institute e-News Archive

Value-based care after COVID-19: What health care leaders need to know

There is no denying that COVID-19 threw an unexpected wrinkle into value-based care contracts — but it might not be exactly the wrinkle we thought we’d see. Initial concerns that COVID-19 might scuttle VBC have calmed, largely...

source: Medical Economics

How accountable care organizations can survive the next health care crisis

Medical providers of all types have faced significant challenges to their finances and operations during the COVID-19 pandemic as patient volume declined and expenses for items such as personal protective equipment soared.

source: Medical Economics

FDA approves Pfizer medication for juvenile arthritis

Pfizer Inc. announced that the U.S. Food and Drug Administration approved XELJANZ for the treatment of children and adolescents two years and older with active polyarticular course juvenile idiopathic arthritis.

source: The Weekly Journal

FDA approves new drug to treat common form of muscular dystrophy based on research from University of Alberta scientist

A University of Alberta researcher's past work has led to a new drug being approved for use in the U.S. to treat patients suffering from Duchenne muscular dystrophy. The drug, viltolarsen, was approved for...

source: Medical Xpress

Research provides new data for medical practices to navigate through COVID-19

As the healthcare industry continues to navigate the COVID-19 pandemic, benchmarking operations through 2020 can provide a strong baseline for medical practices and their ability to survive in the coming months and along their road to recovery.

source: Managed Healthcare Executive

What could be the potential future of Medicare?

As the election approaches, the state of healthcare in the U.S. remains one of the most talked about issues, especially when it comes to Medicare. Many beneficiaries and providers of Medicare are very concerned because the future of this healthcare provider is uncertain.

source: Managed Healthcare Executive

Leaking components from broken muscle fibers activate 'satellite' muscle stem cells

While building a muscle damage model in a cultured system, a research collaboration between Kumamoto University and Nagasaki University in Japan has found that components leaking from broken muscle fibers activate "satellite" muscle stem cells.

source: News-Medical.Net

Stem cells that repair broken bones can also generate arthritic bone spurs

The same stem cells that heal broken bones can also generate arthritic bone spurs called osteophytes, according to a new study in the Annals of the Rheumatic Diseases. Crump is the paper's co-corresponding author, along with Cosimo...

source: News-Medical.Net

The future of precision medicine

Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health,...

source: Rutgers Today

Top 3 challenges of integrating precision medicine with routine care

Precision medicine has emerged in recent years as a potential way to deliver personalized, comprehensive care to patients with a wide range of diseases. In just the last few months, researchers have shown how precision medicine techniques...

source: HealthITAnalytics

Elective surgeries seen driving Q3 medtech comeback, but can it last?

The medtech market is projected to bounce back in the third quarter from the second, buoyed by a recovery in elective procedure volumes that occurred at a faster pace than initially anticipated, according to an outlook from Needham analysts.

source: Medtech Dive

Durvalumab plus tremelimumab active as neoadjuvant bladder cancer treatment

Dual immune-checkpoint blockade with the PD-L1 inhibitor durvalumab and the CTLA-4 inhibitor tremelimumab showed early signs of efficacy in cisplatin-ineligible patients with high-risk localized bladder cancer, according to findings...

source: Urology Times

How advances in medical technology are making office buildings safer

Over the past century, skyscrapers have become the definitive feature of the modern urban landscape, and if you live in a large city, chances are that you work or receive essential services in a high-rise office building.

source: Nature World News

The genomic landscapes of individual melanocytes from human skin

Every cell in the human body has a unique set of somatic mutations, but it remains difficult to comprehensively genotype an individual cell. Here we describe ways to overcome this obstacle in the context of normal human skin, thus offering...

source: Nature

There may be other ways to build DNA and RNA

One of the most fundamental building blocks of life on earth is DNA. This molecule consists of four base pairs and a negatively charged backbone that come together to form the double helix. If life existed elsewhere in the universe, would it use a different genetic information...

source: SciWorthy

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:

Are you a member of NAMCP?	Yes No


Privacy Policy

Browse Categories

Browse by Date

Report: Interoperability does not affect EHR buying decision

Value-based care after COVID-19: What health care leaders need to know

How accountable care organizations can survive the next health care crisis

FDA approves Pfizer medication for juvenile arthritis

FDA approves new drug to treat common form of muscular dystrophy based on research from University of Alberta scientist

Research provides new data for medical practices to navigate through COVID-19

What could be the potential future of Medicare?

Leaking components from broken muscle fibers activate 'satellite' muscle stem cells

Stem cells that repair broken bones can also generate arthritic bone spurs

The future of precision medicine

Top 3 challenges of integrating precision medicine with routine care

Elective surgeries seen driving Q3 medtech comeback, but can it last?

Durvalumab plus tremelimumab active as neoadjuvant bladder cancer treatment

How advances in medical technology are making office buildings safer

The genomic landscapes of individual melanocytes from human skin

There may be other ways to build DNA and RNA

RECOMMENDED:

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News